Combined and interactive effects of environmental and gwas-identified risk factors in ovarian cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 5, 2013, Pages 880-890

  Pearce, Celeste Leigh ^a   Rossing, Mary Anne ^b   Lee, Alice W ^a   Ness, Roberta B ^c   Webb, Penelope M ^d   Chenevix Trench, Georgia ^d   Jordan, Susan M ^d   Stram, Douglas A ^a   Chang Claude, Jenny ^f   Hein, Rebecca ^f   Nickels, Stefan ^f   Lurie, Galina ^e,g   Thompson, Pamela J ^g   Carney, Michael E ^g   Goodman, Marc T ^g   Moysich, Kirsten ^h   Hogdall, Estrid ⁱ   Jensen, Allan ⁱ   Goode, Ellen L ^k   Fridley, Brooke L ^k,ae   Cunningham, Julie M ^l   Vierkant, Robert A ^k   Weber, Rachel Palmieri ^m   Ziogas, Argyrios ^q   Anton Culver, Hoda ^q   Gayther, Simon A ^a,r   Gentry Maharaj, Aleksandra ^r   Menon, Usha ^r   Ramus, Susan J ^a,r   Brinton, Louise ^t   Wentzensen, Nicolas ^t   Lissowska, Jolanta ^u   Garcia Closas, Montserrat ^s   Massuger, Leon F A G ^v   Kiemeney, Lambertus A L M ^m,w,x   Van Altena, Anne M ^v   Aben, Katja K H ^m,x   Berchuck, Andrew ⁿ   Doherty, Jennifer A ^ad   Iversen, Edwin ^o   Mcguire, Valerie ^y   Moorman, Patricia G ^m   Pharoah, Paul ^z   Pike, Malcolm C ^a,aa   Risch, Harvey ^ab   Sieh, Weiva ^y   Stram, Daniel O ^a   Terry, Kathryn L ^ac   Whittemore, Alice ^y   Wu, Anna H ^a   Schildkraut, Joellen M ^m,p   Kjaer, Susanne K ^i,j   more..

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^h ROSWELL PARK CANCER INSTITUTE   (United States)

ⁱ DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

^k Knowledge and Evaluation Research Unit   (United States)

^l MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^m Department of Community and Family Medicine ^*  (Netherlands)

ⁿ Obstetrics and Gynecology   (United States)

^o DUKE UNIVERSITY   (United States)

^p DUKE CANCER INSTITUTE   (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r UNIVERSITY COLLEGE LONDON   (United Kingdom)

^s INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^t NATIONAL CANCER INSTITUTE   (United States)

^u INSTITUTE OF ONCOLOGY   (Poland)

^v Departments of Gynecology   (Netherlands)

^w RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^x Netherlands Comprehensive Cancer Organisation The Netherlands   (Netherlands)

^y STANFORD UNIVERSITY   (United States)

^z UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^aa MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^ab YALE UNIVERSITY   (United States)

^ac BRIGHAM AND WOMEN S HOSPITAL   (United States)

^ad DARTMOUTH MEDICAL SCHOOL   (United States)

^ae UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SCREENING; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; OVARY CANCER; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE TUBE LIGATION;

AGED; CASE-CONTROL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RISK FACTORS;

EID: 84877955398     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-1030-T     Document Type: Article

References (35)

1. American Cancer Society. Cancer Facts and Figures 2011. Atlanta, GA: 2011.
2. Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al. Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA 2011;305:2295-303.
3. Beral V, Doll R, Hermon C, Peto R, Reeves G. Ovarian cancer and oral contraceptives: Collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 2008;371:303-14.
4. Pike MC, Pearce CL, Peters R, Cozen W, Wan P, Wu AH. Hormonal factors and the risk of invasive ovarian cancer: A population-based case-control study. Fertil Steril 2004;82:186-95.
5. Whiteman DC, Murphy MF, Cook LS, Cramer DW, Hartge P, Marchbanks PA, et al. Multiple births and risk of epithelial ovarian cancer. J Natl Cancer Inst 2000;92:1172-7.
6. Tung KH, Goodman MT, Wu AH, McDuffie K, Wilkens LR, Kolonel LN, et al. Reproductive factors and epithelial ovarian cancer risk by histologic type: A multiethnic case-control study. Am J Epidemiol 2003;158:629-38.
7. Cibula D, Widschwendter M, Majek O, Dusek L. Tubal ligation and the risk of ovarian cancer: Review and meta-analysis. Hum Reprod Update 2011;17:55-67.
8. Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: A pooled analysis of case-control studies. Lancet Oncol 2012;13:385-94.
9. Auranen A, Pukkala E, Makinen J, Sankila R, Grenman S, Salmi T. Cancer incidence in the first-degree relatives of ovarian cancer patients. Br J Cancer 1996;74:280-4.
10. Antoniou AC, Easton DF. Risk prediction models for familial breast cancer. Future Oncol 2006;2:257-74.
11. Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2010;42:880-4.
12. Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 2010;42:874-9.
13. Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009;41:996-1000.
14. Pearce CL, Doherty JA, Van Den Berg DJ, Moysich K, Hsu C, Cushing-Haugen KL, et al. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. Hum Mol Genet 2011;20:2263-72.
15. Schildkraut JM, Goode EL, Clyde MA, Iversen ES, Moorman PG, Berchuck A, et al. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2009;69:2349-57.
16. OCAC-The Ovarian Cancer Association Consortium. [updated September 23, 2011]; Available from: Http://www.srl.cam.ac.uk/consortia/ocac/index.html.
17. Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control 2008;19: 1357-64.
18. Lurie G, Terry KL, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, et al. Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk. Cancer Causes Control 2010;21:1731-41.
19. Ness RB, Dodge RC, Edwards RP, Baker JA, Moysich KB. Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. Ann Epidemiol 2011;21:188-96.
20. Cunningham JM, Vierkant RA, Sellers TA, Phelan C, Rider DN, Liebow M, et al. Cell cycle genes and ovarian cancer susceptibility: A tagSNP analysis. Br J Cancer 2009;101:1461-8.
21. Moorman PG, Calingaert B, Palmieri RT, Iversen ES, Bentley RC, Halabi S, et al. Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women. Am J Epidemiol 2008;167: 1059-69.
22. Ziogas A, Gildea M, Cohen P, Bringman D, Taylor TH, Seminara D, et al. Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 2000;9:103-11.
23. Wu AH, Pearce CL, Tseng CC, Templeman C, Pike MC. Markers of inflammation and risk of ovarian cancer in Los Angeles County. Int J Cancer 2009;124:1409-15.
24. McGuire V, Felberg A, Mills M, Ostrow KL, DiCioccio R, John EM, et al. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. Am J Epidemiol 2004;160:613-8.
25. Royar J, Becher H, Chang-Claude J. Low-dose oral contraceptives: Protective effect on ovarian cancer risk. Int J Cancer 2001;95:370-4.
26. Balogun N, Gentry-Maharaj A, Wozniak EL, Lim A, Ryan A, Ramus SJ, et al. Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking study. J Clin Epidemiol 2011;64:525-30.
27. Glud E, Kjaer SK, Thomsen BL, Hogdall C, Christensen L, Hogdall E, et al. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med 2004;164:2253-9.
28. Merritt MA, Green AC, Nagle CM, Webb PM. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer 2008;122:170-6.
29. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: A gentle introduction to imputation of missing values. J Clin Epidemiol 2006;59:1087-91.
30. Risch HA, Marrett LD, Jain M, Howe GR. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol 1996;144:363-72.
31. Yang HP, Trabert B, Murphy MA, Sherman ME, Sampson JN, Brinton LA, et al. Ovarian cancer risk factors by histologic subtypes in the NIHAARP diet and health study. Int J Cancer 2011;131:938-48.
32. Parazzini F, Chiaffarino F, Negri E, Surace M, Benzi G, Franceschi S, et al. Risk factors for different histological types of ovarian cancer. Int J Gynecol Cancer 2004;14:431-6.
33. Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, et al. Risk factors for invasive epithelial ovarian cancer: Results from a Swedish case-control study.AmJ Epidemiol 2002;156:363-73.
34. Kurian AW, Balise RR, McGuire V, Whittemore AS. Histologic types of epithelial ovarian cancer: Have they different risk factors? Gynecol Oncol 2005;96:520-30.
35. Chiaffarino F, Parazzini F, Bosetti C, Franceschi S, Talamini R, Canzonieri V, et al. Risk factors for ovarian cancer histotypes. Eur J Cancer 2007;43:1208-13.